Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03092037 · ClinicalTrials.gov registry record
Pharmacogenomics of Contraception: Genetic Variants and Etonogestrel Pharmacokinetics
A clinical trial of Contraception, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 900
- Enrollment target
- 1
- Study location
NCT03092037 is a study of Contraception that has completed, run by University of Colorado, Denver. The registered enrollment target is 900 participants, above the 442-participant average among 72 other Contraception trials with a reported enrollment target (104% higher). The trial reports 1 study location across 1 state.
The verdict
NCT03092037, a study of Contraception, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 900 participants
- Enrollment target
- 1
- Study location
Study Summary
The proposed study will investigate the relationship between genetic variants and serum contraceptive hormone levels, specifically the progestin etonogestrel. This study will provide the foundation for future pharmacogenomic investigations of more commonly used contraceptive methods with higher failure rates.
Conditions Studied
Interventions
- PROCEDURE Blood draw
Study Locations (1)
Colorado
- University of Colorado Denver - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 900 participants |
| Start Date | 2017-03-23 |
| Est. Completion | 2022-04-29 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03092037
The ClinicalTrials.gov registry entry for NCT03092037 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 900 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 442-participant average among 72 other Contraception trials with a reported enrollment target (104% higher). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Contraception appearing as the primary indexed condition, and to 1 intervention - of which Blood draw is the first listed.
NCT03092037 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT03092037 about?
NCT03092037 is a clinical study titled "Pharmacogenomics of Contraception: Genetic Variants and Etonogestrel Pharmacokinetics". The proposed study will investigate the relationship between genetic variants and serum contraceptive hormone levels, specifically the progestin etonogestrel. This study will provide the foundation for future pharmacogenomic investigations of more commonly used contraceptive methods with higher fail...
What is the current status of trial NCT03092037?
This trial is currently completed. The enrollment target is 900 participants. The study started on 2017-03-23. Estimated completion is 2022-04-29.
What conditions does trial NCT03092037 study?
This clinical trial studies the following conditions: Contraception.
What interventions are being tested in trial NCT03092037?
The interventions under investigation include: Blood draw (PROCEDURE).
Who is sponsoring clinical trial NCT03092037?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03092037 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Contraception
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Oral Contraceptive Pill (OCP) Pharmacogenomics
RECRUITING · Phase 4
-
Intravenous Ketorolac Administration to Attenuate Post-procedural Pain Associated With Intrauterine Device Placement
RECRUITING · Phase 4
-
Patient-clinical Linkages to Improve Trust and Engagement in Postpartum Healthcare
RECRUITING · NA
-
Empathy Through Pain Control: Lidocaine Paracervical Block for IUD Placements
RECRUITING · NA
-
Hormonal Contraception Access Through Pharmacist Prescribing Implementation
RECRUITING · NA
-
Prospective Multi-Center Trial for FemBloc Permanent Birth Control
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.